Inhibition of histone deacetylases enhances the function of serotoninergic neurons in organotypic raphe slice cultures

Neuroscience Letters
Nozomi AsaokaShuji Kaneko

Abstract

Inhibition of histone deacetylases (HDACs) is a promising approach for the treatment of mood disorders. However, the effects of HDAC inhibition on the serotonin (5-HT) system, a common target for psychiatric disorders, are poorly understood. Here, we show that a broad-spectrum HDAC inhibitor, trichostatin A (TSA), enhances the function of 5-HT neurons in organotypic raphe slice cultures. Sustained treatment with TSA (1μM) for 2 or 4 days significantly increased the 5-HT tissue content and tryptophan hydroxylase 2 (TPH2) expression, which were accompanied by hyper-acetylation of histone H3 in the promoter region of the TPH2 gene. TSA treatment for 4 days increased the extracellular 5-HT level, which was significantly suppressed in the presence of the selective AMPA receptor (AMPAR) antagonist NBQX. Moreover, the expression of both the AMPAR subunit GluA2 and Ca(2+)/calmodulin-dependent kinase II α (CaMKIIα) mRNAs were significantly increased by TSA treatment. Co-treatment with the CaMKII inhibitors KN-62 and KN-93 prevented the TSA-induced increase in 5-HT release, but had no effect on the increases in 5-HT tissue content. These results suggest that inhibition of HDACs increases 5-HT synthesis and release by epigenetic mechanism...Continue Reading

References

Jan 4, 2003·Science·Diego J WaltherMichael Bader
Feb 21, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Lee E SchechterSharon Rosenzweig-Lipson
Sep 2, 2006·Biological Psychiatry·Frederick A SchroederSchahram Akbarian
May 19, 2007·The European Journal of Neuroscience·S E GartsideS J Judge
Jun 8, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Christopher G VecseyMarcelo A Wood
Dec 27, 2008·Neuron·Emiliana BorrelliPaolo Sassone-Corsi
Jan 17, 2009·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Francis Rodriguez BambicoGabriella Gobbi
Jun 26, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Mohd W AkhtarLisa M Monteggia
Jul 29, 2009·Neurobiology of Disease·Giuseppe FaracoAlberto Chiarugi
Nov 10, 2009·Nature Neuroscience·Chris MurgatroydDietmar Spengler
Jul 21, 2010·Current Opinion in Psychiatry·Marc SchroederHelge Frieling
Apr 26, 2011·Nature Neuroscience·Anders S KristensenStephen F Traynelis
Mar 1, 2012·Proceedings of the National Academy of Sciences of the United States of America·Kyung-Min NohR Suzanne Zukin
Mar 30, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Julie EspallerguesOlivier Berton
Oct 12, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ashley N HutchinsonAnne E West
Aug 24, 2013·Frontiers in Psychiatry·Florian Joachim Raabe, Dietmar Spengler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.